Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis
暂无分享,去创建一个
R. Gelber | A. Goldhirsch | C. Rudenstam | R. Golouh | I. Russell | W. Hartmann | L. Holloway | B. Davis | G. Locher | R. Reed | Johan Süe‐Söderbergh
[1] A. Goldhirsch,et al. Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. , 1985, Human pathology.
[2] G. Bonadonna,et al. Adjuvant systemic therapy for resectable breast cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] I. Henderson. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice? , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Zelen,et al. A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. , 1985, Cancer research.
[5] Ludwig Breast. Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Neville,et al. Prognostic significance of peritumoral vascular invasion in breast cancer. , 1984, British Journal of Cancer.
[7] I. Taylor,et al. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. , 1984, Cancer research.
[8] A. Goldhirsch,et al. Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor. , 1984, European journal of cancer & clinical oncology.
[9] B. Fisher,et al. Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure , 1984, Cancer.
[10] C. Redmond,et al. Pathologic findings from the national surgical adjuvant breast project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation , 1983, Cancer.
[11] J. Haybittle,et al. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. , 1982, British Journal of Cancer.
[12] R. Rubens,et al. HISTOLOGICAL GRADE AND RESPONSE TO ENDOCRINE THERAPY IN BREAST CANCER , 1981, The Lancet.
[13] H. Johansen,et al. Selection of High Risk Groups Among Prognostically Favorable Patients with Breast Cancer: An Analysis of the Value of Prospective Grading of Tumor Anaplasia in 1,048 Patients , 1981, Annals of surgery.
[14] C. Redmond,et al. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five‐year treatment failure , 1980, Cancer.
[15] C. Redmond,et al. Histologic grading of breast cancer. , 1980, Pathology annual.
[16] N. M. Drayer,et al. STERILITY PROBLEMS AND THE DIABETIC , 1978, The Lancet.
[17] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[18] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[19] M. Marshall. TUBERCULOSIS IN HONG KONG. , 1964, Lancet.
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[21] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.